Detection of diabetic polyneuropathy in a family medicine clinic by using monofilament
Sažetak
Background/Aim. Diabetic polyneuropathy (DPN) is the most common microvascular complication of diabetes mellitus (DM), which may be present at the time of disease detection. Screening for DPN is performed for the patients with type 2 diabetes at the time of diagnosis and for type 1 diabetes 5 years after diagnosis. The primary aim of this study was to determine the prevalence of DNP among family medicine patients with DM aged 18 to 70 years using nylon monofilament. Methods. The cross-sectional study estimated the prevalence of DPN among primary care patients with DM in Banja Luka, Republic of Srpska, Bosnia and Herzegovina. Semmes-Weinstein nylon 10 g monofilament was used to detect DPN. Age, gender, duration of DM, type of therapy, symptoms, glycosylated hemoglobin (HbA1c), and risk factors (hypertension, smoking, dyslipidemia, obesity, physical inactivity) were analyzed. Data collection took place from June 1st, 2017 to May 31st, 2018. Results. The study included 228 patients, 132 (57.9%) men and 96 (42.1%) women. There was a statistically significant difference in the presence of all symptoms of DPN (tingling, burning, light burning, and stinging) among patients with different duration of DM (p < 0.01). Multivariate logistic regression revealed that patients who had hypertension [odds ratio (OR) = 26.2; 95% confidence interval (CI): 4.070–168.488; p = 0.001], used oral antidiabetic therapy (OR = 12.3; 95% CI: 1.300–116.309; p = 0.029), had tingling (OR = 5.2; 95% CI: 1.431–18.571; p = 0.012) and a longer duration of diabetes (OR = 4.27; 95% CI: 1.983–9.175; p = 0.000) were more likely to have DPN. Conclusion. The prevalence of DPN in family medicine patients with DM using nylon monofilament was 24.2%. Determinants of DNP were the presence of symptoms of tingling, duration of diabetes, hypertension, and the use of oral antidiabetic therapy alone.
Reference
Albers JW, Pop-Busui R. Diabetic neuropathy: mechanisms, emerging treatments, and subtypes. Curr Neurol Neurosci Rep 2014; 14(8): 473.
Dyck PJ, Albers JW, Andersen H, Arezzo JC, Biessels GJ, Bril V, et al. Diabetic polyneuropathies: update on research defini-tion, diagnostic criteria and estimation of severity. Diabetes Metab Res Rev 2011; 27(7): 620–8.
Lee CC, Perkins BA, Kayaniyil S, Harris SB, Retnakaran R, Ger-stein HC, et al. Peripheral neuropathy and nerve dysfunction in individuals at high risk for type 2 diabetes: the PROMISE cohort. Diabetes Care 2015; 38(5): 793–800.
Perkins BA, Orszag A, Ngo M, Ng E, New P, Bril V. Prediction of Incident Diabetic Neuropathy Using the Monofilament Examination. A 4-year prospective study. Diabetes Care 2010; 33(7): 1549‒54.
Abbott CA, Malik RA, van Ross ER, Kulkarni J, Boulton AJ. Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the U.K. Diabetes Care 2011; 34(10): 2220‒4.
Pop-Busui R, Boulton AJ, Feldman EL, Bril V, Freeman R, Malik RA, et al. Diabetic Neuropathy: A Position Statement by the American Diabetes Association. Diabetes Care 2017; 40(1): 136‒54.
Boulton AJM. The pathway to foot ulceration in diabetes. Med Clin North Am 2013; 97(5): 775–90.
Morrison S, Colberg SR, Parson HK, Vinik AI. Relation between risk of falling and postural sway complexity in diabetes. Gait Posture 2012; 35(4): 662–8.
American Diabetes Association. Standards of medical care in dia-betes: 2007. Diabetes Care 2007; 30(Suppl 1): S4–S41.
International Diabetes Federation. IDF Diabetes Atlas. 7th ed. Brussels: International Diabetes Federation; 2015.
Park JH, Kim DS. The Necessity of the Simple Tests for Dia-betic Peripheral Neuropathy in Type 2 Diabetes Mellitus Pa-tients without Neuropathic Symptoms in Clinical Practice. Diabetes Metab J 2018; 42(5): 442‒6.
Boulton AJM, Rayaz MA. Neuropathy of Impaired Glucose Tolerance and Its Measurement Diabetes Care 2010; 33(1): 207–9.
Putz Z, Tabák AG, Tóth N, Istenes I, Németh N, Gandhi RA, et al. Noninvasive Evaluation of Neural Impairment in Subjects With Impaired Glucose Tolerance. Diabetes Care 2009; 32(1): 181–3.
Vincent AM, Hinder LM, Pop-Busui R, Feldman EL. Hyper-lipidemia: a new therapeutic target for diabetic neuropathy. J Peripher Nerv Syst 2009; 14(4): 257‒67.
Stino AM, Smith AG. Peripheral neuropathy in prediabetes and the metabolic syndrome. J Diabetes Investig 2017; 8(5): 646–55.
Chetpet A, Dikshit B, Phalgune D. Evaluating a Risk Score for Lower Extremity Amputation in Patients with Diabetic Foot Infections. J Clin Diagn Res 2018; 12(10): PC14‒9.
Del Core MA, Ahn J, Lewis RB III, Raspovic KM, Lalli TAJ, Wukich DK. The Evaluation and Treatment of Diabetic Foot Ulcers and Diabetic Foot Infections. Foot Ankle Orthopae-dics 2018; 3(3): 1‒11.
Iftikhar M, Hussain A, Rizvi A. Frequency of peripheral neu-ropathy in patients with diabetes mellitus. Ayub Med Coll Abbottabad 2014; 26(4): 584‒6.
Vincent AM, Callaghan BC, Smith AL, Feldman EL. Diabetic neuropathy: cellular mechanisms as therapeutic targets. Nat Rev Neurol 2011; 7(10): 573–83.
Pop-Busui R, Lu J, Brooks MM, Albert S, Althouse AD, Escobedo J, et al. Impact of glycemic control strategies on the progres-sion of diabetic peripheral neuropathy in the Bypass Angio-plasty Revascularization Investigation 2 Diabetes (BARI 2D) Cohort. Diabetes Care 2013; 36(10): 3208‒15.
American Diabetes Association. Standards of medical care in dia-betes ‒ 2015. Diabetes Care 2015; 38(Suppl 1): S1‒S93.
National Expert Commission for the Development and Implementa-tion of Good Clinical Practice. National Diabetes Mellitus Good Clinical Practice Guide. 2th Ed. Belgrade: Ministry of Health of the Republic of Serbia; 2012. (Serbian)
WHO. Global recommendations on physical activity for health. Geneva: World Health Organization; 2010.
Salvotelli L, Stoico V, Perrone F, Cacciatori V, Negri C, Brangani C, et al. Prevalence of neuropathy in type 2 diabetic patients and its association with other diabetes complications: The Ve-rona Diabetic Foot Screening Program. J Diabetes Complica-tions 2015; 29(8): 1066‒70.
Amour AA, Chamba N, Kayandabila J, Lyaruu IA, Marieke D, Shao ER, et al. Prevalence, Patterns, and Factors Associated with Peripheral Neuropathies among Diabetic Patients at Ter-tiary Hospital in the Kilimanjaro Region: Descriptive Cross-Sectional Study from North-Eastern Tanzania. Intl J Endo-crinol 2019; 2019: 5404781.
Gill HK, Yadav SB, Ramesh V, Bhatia E. A prospective study of prevalence and association of peripheral neuropathy in In-dian patients with newly diagnosed type 2 diabetes mellitus. J Postgrad Med 2014; 60(3): 270‒5.
Khawaja N, Abu-Shennar J, Saleh M, Dahbour SS, Khader YS, Aj-louni KM. The prevalence and risk factors of peripheral neu-ropathy among patients with type 2 diabetes mellitus; the case of Jordan. Diabetol Metab Syndr 2018; 10: 8.
Aslam A, Singh J, Rajbhandari S. Prevalence of Painful Diabet-ic Neuropathy Using the Self-Completed Leeds Assessment of Neuropathic Symptoms and Signs Questionnaire in a Popula-tion with Diabetes. Can J Diabetes 2015; 39(4): 285–95.
Naqvi SSZH, Imani S, Hosseinifard H, Wen QL, Shahzad MN, Ijaz I, et al. Associations of serum low-density lipoprotein and systolic blood pressure levels with type 2 diabetic patients with and without peripheral neuropathy: systemic review, me-ta-analysis and meta-regression analysis of observational stud-ies. BMC Endocr Disord. 2019; 19(1): 125.
Li L, Chenb J, Wanga J, Caia D. Prevalence and risk factors of diabetic peripheral neuropathy in Type 2 diabetes mellitus pa-tients with overweight/obese in Guangdong province, China. Prim Care Diabetes 2014; 9(3): 191‒5.
Darivemula S, Nagoor K, Patan SK, Reddy NB, Deepthi CS, Chit-tooru CS. Prevalence and Its Associated Determinants of Dia-betic Peripheral Neuropathy (DPN) in Individuals Having Type-2 Diabetes Mellitus in Rural South India. Indian J Community Med 2019; 44(2): 88–91.
Lazo Mde L, Bernabé-Ortiz A, Pinto ME, Ticse R, Malaga G, Sacksteder K, et al. Diabetic Peripheral Neuropathy in Ambula-tory Patients with Type 2 Diabetes in a General Hospital in a Middle Income Country: A Cross-Sectional Study. PLoS One. 2014; 9 (5): e95403.